CLPB Gene 3-methylglutaconic aciduria type 7 with cataracts neurologic involvement and neutropenia Genetic Test
Test Name: CLPB Gene 3-methylglutaconic aciduria type 7 with cataracts neurologic involvement and neutropenia Genetic Test
Components: Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for CLPB Gene 3-methylglutaconic aciduria type 7, with cataracts, neurologic involvement and neutropenia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with 3-methylglutaconic aciduria type 7, with cataracts, neurologic involvement and neutropenia.
Test Details: The CLPB gene is associated with a rare genetic disorder called 3-methylglutaconic aciduria type 7. This disorder is characterized by the presence of cataracts, neurologic involvement, and neutropenia (low levels of neutrophils, a type of white blood cell). NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations. In the case of 3-methylglutaconic aciduria type 7, NGS genetic testing can be used to identify mutations or variations in the CLPB gene that are responsible for the disorder. By analyzing the patient’s DNA, NGS genetic testing can provide valuable information about the specific genetic changes present in the CLPB gene, helping to confirm a diagnosis of 3-methylglutaconic aciduria type 7. This information can also be used for genetic counseling and to guide potential treatment options for the patient.
Test Name | CLPB Gene 3-methylglutaconic aciduria type 7 with cataracts neurologic involvement and neutropenia Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CLPB Gene 3-methylglutaconic aciduria type 7, with cataracts, neurologic involvement and neutropenia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with 3-methylglutaconic aciduria type 7, with cataracts, neurologic involvement and neutropenia |
Test Details |
The CLPB gene is associated with a rare genetic disorder called 3-methylglutaconic aciduria type 7. This disorder is characterized by the presence of cataracts, neurologic involvement, and neutropenia (low levels of neutrophils, a type of white blood cell). NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations. In the case of 3-methylglutaconic aciduria type 7, NGS genetic testing can be used to identify mutations or variations in the CLPB gene that are responsible for the disorder. By analyzing the patient’s DNA, NGS genetic testing can provide valuable information about the specific genetic changes present in the CLPB gene, helping to confirm a diagnosis of 3-methylglutaconic aciduria type 7. This information can also be used for genetic counseling and to guide potential treatment options for the patient. |